Brian Skorney
Stock Analyst at Robert W. Baird
(0.12)
# 4,574
Out of 4,651 analysts
857
Total ratings
36.8%
Success rate
-5.5%
Average return
Main Sectors:
Stocks Rated by Brian Skorney
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintained: Buy | $400 → $514 | $366.81 | +40.13% | 4 | Aug 7, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $129 → $123 | $100.64 | +22.22% | 44 | Aug 6, 2026 | |
| AMGN Amgen | Maintained: Sell | $215 → $230 | $415.21 | -44.61% | 52 | Aug 5, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $252 → $280 | $244.96 | +14.30% | 3 | Aug 4, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $186 → $225 | $152.72 | +47.33% | 53 | Jul 31, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $742 → $761 | $803.48 | -5.29% | 64 | Jul 31, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Sell | $320 → $350 | $505.75 | -30.80% | 59 | Jul 7, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $27 → $32 | $10.77 | +197.26% | 18 | Jun 23, 2026 | |
| ANRO Alto Neuroscience | Maintained: Buy | $38 → $36 | $32.14 | +12.01% | 15 | May 18, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $241 → $246 | $213.67 | +15.13% | 3 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $97 | $62.35 | +55.57% | 6 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $20 | $18.10 | +10.50% | 108 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $108 → $145 | $138.36 | +4.80% | 81 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $250 | $209.83 | +19.14% | 97 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $84.70 | -26.80% | 16 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 → $52 | $14.64 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $32 | $25.70 | n/a | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $25.31 | n/a | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $12.56 | n/a | 1 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $20 | $13.16 | n/a | 37 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $4.84 | n/a | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $4.67 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $27.05 | n/a | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $30 | $3.99 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $0.2676 | n/a | 14 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $34.20 | n/a | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $16.97 | n/a | 24 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $41.82 | n/a | 16 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $32.95 | n/a | 14 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $15.15 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $7.38 | n/a | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 | $3.05 | n/a | 6 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 → $146 | $11.91 | n/a | 5 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $3.27 | n/a | 11 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $1.80 | n/a | 8 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $144 | $58.47 | n/a | 1 | Mar 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $83 → $138 | $347.48 | n/a | 5 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $42 | $123.74 | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $67.34 | n/a | 11 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $13 | $21.19 | n/a | 7 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.58 | n/a | 3 | Jan 22, 2015 |
Praxis Precision Medicines
Aug 7, 2026
Maintained: Buy
Price Target: $400 → $514
Current: $366.81
Upside: +40.13%
Mirum Pharmaceuticals
Aug 6, 2026
Maintained: Buy
Price Target: $129 → $123
Current: $100.64
Upside: +22.22%
Amgen
Aug 5, 2026
Maintained: Sell
Price Target: $215 → $230
Current: $415.21
Upside: -44.61%
Jazz Pharmaceuticals
Aug 4, 2026
Maintained: Buy
Price Target: $252 → $280
Current: $244.96
Upside: +14.30%
Neurocrine Biosciences
Jul 31, 2026
Maintained: Buy
Price Target: $186 → $225
Current: $152.72
Upside: +47.33%
Regeneron Pharmaceuticals
Jul 31, 2026
Maintained: Hold
Price Target: $742 → $761
Current: $803.48
Upside: -5.29%
Vertex Pharmaceuticals
Jul 7, 2026
Maintained: Sell
Price Target: $320 → $350
Current: $505.75
Upside: -30.80%
REGENXBIO
Jun 23, 2026
Maintained: Buy
Price Target: $27 → $32
Current: $10.77
Upside: +197.26%
Alto Neuroscience
May 18, 2026
Maintained: Buy
Price Target: $38 → $36
Current: $32.14
Upside: +12.01%
Axsome Therapeutics
May 5, 2026
Maintained: Buy
Price Target: $241 → $246
Current: $213.67
Upside: +15.13%
Mar 9, 2026
Maintained: Buy
Price Target: $63 → $97
Current: $62.35
Upside: +55.57%
Feb 26, 2026
Maintained: Hold
Price Target: $22 → $20
Current: $18.10
Upside: +10.50%
Feb 11, 2026
Maintained: Hold
Price Target: $108 → $145
Current: $138.36
Upside: +4.80%
Oct 31, 2025
Maintained: Buy
Price Target: $255 → $250
Current: $209.83
Upside: +19.14%
Sep 26, 2025
Maintained: Buy
Price Target: $62
Current: $84.70
Upside: -26.80%
Aug 12, 2025
Maintained: Buy
Price Target: $57 → $52
Current: $14.64
Upside: n/a
Jun 18, 2025
Maintained: Buy
Price Target: $46 → $32
Current: $25.70
Upside: n/a
Feb 7, 2025
Maintained: Buy
Price Target: $25 → $17
Current: $25.31
Upside: n/a
Dec 12, 2024
Initiated Coverage: Buy
Price Target: $30
Current: $12.56
Upside: n/a
Nov 26, 2024
Maintained: Buy
Price Target: $26 → $20
Current: $13.16
Upside: n/a
Nov 20, 2024
Maintained: Buy
Price Target: $28
Current: $4.84
Upside: n/a
Nov 6, 2024
Maintained: Hold
Price Target: $4
Current: $4.67
Upside: n/a
Sep 5, 2024
Initiated Coverage: Buy
Price Target: $26
Current: $27.05
Upside: n/a
Dec 14, 2023
Downgraded: Hold
Price Target: $28 → $30
Current: $3.99
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $7.5
Current: $0.2676
Upside: n/a
Nov 10, 2022
Maintained: Buy
Price Target: $28
Current: $34.20
Upside: n/a
Nov 7, 2022
Maintained: Hold
Price Target: $8
Current: $16.97
Upside: n/a
Sep 8, 2022
Maintained: Hold
Price Target: $6
Current: $41.82
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $15
Current: $32.95
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $16
Current: $15.15
Upside: n/a
Aug 12, 2021
Initiated Coverage: Buy
Price Target: $34
Current: $7.38
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $39
Current: $3.05
Upside: n/a
Aug 5, 2021
Maintained: Hold
Price Target: $85 → $146
Current: $11.91
Upside: n/a
May 10, 2021
Maintained: Hold
Price Target: $6
Current: $3.27
Upside: n/a
Nov 1, 2018
Maintained: Buy
Price Target: $7 → $3
Current: $1.80
Upside: n/a
Mar 27, 2018
Maintained: Buy
Price Target: $144
Current: $58.47
Upside: n/a
Feb 28, 2018
Reiterated: Hold
Price Target: $83 → $138
Current: $347.48
Upside: n/a
Jan 4, 2018
Reiterated: Buy
Price Target: $32 → $42
Current: $123.74
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $115
Current: $67.34
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $14 → $13
Current: $21.19
Upside: n/a
Jan 22, 2015
Reiterated: Buy
Price Target: $11
Current: $4.58
Upside: n/a